Plasma-derived proteins in airway defence, disease and repair of epithelial injury

European Respiratory Journal

Volumn 11, Issue 4, 1998, Pages 958-970

  Persson, C G A ^a,b   Erjefalt J S ^c,d   Greiff, L ^a   Andersson, M ^a   Erjefalt I ^b   Godfrey, R W A ^c   Korsgren, M ^d   Linden, M ^b   Sundler, F ^d   Svensson, C ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Mucosal biology in vivo; Plasma exudation; Plasma proteins

Indexed keywords

PLASMA PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; LAMINA PROPRIA; LUNG INJURY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; TARGET CELL;

ANIMALS; ASTHMA; BLOOD PROTEINS; EPITHELIUM; EXUDATES AND TRANSUDATES; HUMANS; MUCOUS MEMBRANE; MUCUS; RESPIRATORY SYSTEM;

EID: 14444278046     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11040958     Document Type: Article

References (85)

1. Persson CGA, Erjefält I. Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen. Acta Physiol Scand 1986; 126: 615-616.
2. Persson CGA, Erjefält I, Alkner U, et al. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy 1991; 21: 17-24.
3. Erjefält JS, Sundler F, Persson CGA. Eosinophils, neutrophils and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med 1996; 153: 1666-1674.
4. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Microcirculation-derived factors in airway epithelial repair in vivo. Microvasc Res 1994; 48: 161-178.
5. Persson CGA, Andersson M, Greiff L, et al. Airway permeability. Clin Exp Allergy 1995; 23: 807-814.
6. Erjefält I, Persson CGA. Inflammatory passage of plasma macromolecules into airway tissue and lumen. Pulm Pharmacol 1989; 2: 93-102.
7. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Epithelial pathways for luminal entry of bulk plasma. Clin Exp Allergy 1995; 25: 187-195.
8. Persson CGA, Gustafsson B, Luts A, Sundler F, Erjefält I. Toluene diisocyanate produces an increase in airway tone that outlasts the inflammatory exudation phase. Clin Exp Allergy 1991; 21: 715-724.
9. Erjefält I, Persson CGA. Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy 1992; 22: 854-862.
10. Erjefält I, Persson CGA. Effects of budesonide on allergen- and toluene diisocyanate (TDI)-induced late phase airway exudation of bulk plasma. Am J Respir Crit Care Med 1995; 151: A223.
11. Persson CGA, Erjefält I, Andersson P. Leakage of macromolecules from guinea-pig tracheobronchial microcirculation. Effects of allergen, leukotrienes, tachykinins and anti-asthma drugs. Acta Physiol Scan 1986; 127:95-105.
12. Hultström D, Svensjö E. Intravital and electron microscopic study of bradykinin-induced vascular permeability changes using FITC-dextran as a tracer. J Pathol 1979; 129: 125-133.
13. McDonald M. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am J Physiol 1994; 266: L61-83.
14. Grega GJ, Persson CGA, Svensjö E. Endothelial cell reactions to inflammatory mediators assessed in vivo by fluid and solute flux analysis. In: Ryan US, ed. Endothelial Cells. Boca Raton, FL, USA, CRC, 1988; pp. 103-122.
15. Persson CGA, Erjefält JS, Andersson M, Greiff L, Svensson C. Extravasation, lamina propria flooding and lumenal entry of bulk plasma exudate in mucosal defence, inflammation, and repair. Pulm Pharmacol 1996; 9: 129-139.
16. Svensson C, Grönneberg R, Andersson M, et al. Allergen challenge-induced entry of alpha-2-macroglobulin and tryptase into human nasal and bronchial airways. J Allergy Clin Immunol 1995; 96: 239-246.
17. Persson CGA, Svensson C, Greiff L, et al. I. Editorial. The use of the nose to study the inflammatory response of the respiratory tract. Thorax 1992; 47: 993-1000.
18. Svensson C, Greiff L, Andersson M, Alkner U, Grönneberg R, Persson CGA. Antiallergic actions of high topical doses of terbutaline in human nasal airways. Allergy 1995; 50: 884-890.
19. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 1993; 178: 2147-2136.
20. Roman J, McDonald JA. Fibronectins and fibronectin receptors in lung development, injury, and repair. Crystal RG, West JB et al., eds. Lung: Scientific Foundations, 2nd ed. Philadelphia, Lippincott 1997; pp. 737-757.
21. Salomonsson P, Grönneberg R, Gilljam H, et al. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis 1992; 146: 1535-1542.
22. Schwaeble WJ, Whaley K. Complement and antigen-antibody complexes. In: Kay AB, ed. Allergy and Allergic Diseases. London, Blackwells, 1997; pp. 307-323.
23. Kaplan AP, Silverberg M, Reddigari S. Intrinsic coagulation/bradykinin-forming cascade. In: Kay AB, ed. Allergy and Allergic Diseases. London, Blackwells, 1997; pp. 324-339.
24. Blombäck B, Blombäck M, Edman P, Hessel B. Human fibrinopeptides: isolation, characterization and structure. Biochim Biophys Acta 1966; 115: 371-380.
25. Gray AJ, Reeves JT, Harrisson NK, Winlove P, Laurent GJ. Growth factors for human fibroblasts in the solute remaining after clot formation. J Cell Sci 1990; 96: 271-274.
26. Grainger DJ, Kemp PR, Metcalfe JC, et al. The serum concentration of active transforming growth factor-B is severely depressed in advanced atherosclerosis. Nature Med 1995; 1: 74-79.
27. 2-Macroglobulin, Its Receptor, and Related Proteins. New York, New York Academy of Science, 1994.
28. Erjefält I, Persson CGA. Pharmacological control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991; 143: 1008-1014.
29. Erjefält I, Luts A, Persson CGA. Appearance of airway absorption and exudation tracers in guinea-pig tracheobronchial lymph nodes. J Appl Physiol 1993; 74: 817-824.
30. Godfrey RWA, Severs NJ, Jeffery PK. Freeze-fracture morphology and quantification of human bronchial epithelial tight junctions. Am J Respir Cell Mol 1992; 6: 453-458.
31. Claude P. Morphological factors influencing transepithelial permeability: a model for the resistance of the zonula occludens. J Membr Biol 1978; 39: 219-232.
32. Persson CGA, Erjefält I, Gustafsson B, Luts A. Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol 1990; 92: 148-153.
33. Greiff L, Alkner U, Pipkorn U, Persson CGA. The "nasal pool" device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990; 20: 253-259.
34. Prescott T, Kaliner MA. Vascular mechanisms in rhinitis. In: Busse WW, Holgate ST, eds. Asthma and Rhinitis. Oxford, Blackwells 1995; pp. 777-790.
35. Greiff L, Erjefält I, Wollmer P, et al. Effects of nicotine on the human nasal airway mucosa. Thorax 1993; 48: 651-655.
36. Greiff L, Svensson C, Andersson M, Persson CGA. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995; 225-229.
37. 2-macroglobulin. Thorax 1997; 52: 964-968.
38. Sanico AM, Atsuta S, Proud D, Togias A. Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation. J Allergy Clin Immunol 1997; 100: 632-641.
39. Persson CGA, Erjefält I, Sundler F. Airway microvascular and epithelial leakage of plasma induced by PAF-acether and capsaicin. Am Rev Respir Dis 1987; 135: A401.
40. Asakura K, Narita S, Kojima T, Saito H, Kataura A. Changes in nasal airway resistance and secretory response in the guinea-pig after nasal challenge with capsaicin and histamine. Ear Arch Otorhinolaryngol 1994; 251: 224-228.
41. Svensson C, Baumgarten CR, Pipkorn U, Alkner U, Persson CGA. Reversibility and reproducibility of histamine-induced plasma leakage in the human nasal airways. Thorax 1989; 44: 13-18.
42. Berman AR, Liu MC, Wagner EM, Proud D. Dissociation of bradykinin induced plasma exudation and reactivity in the peripheral airways. Am J Respir Crit Care Med 1996; 154: 418-423.
43. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Mucosal nitric oxide may tonically suppress airways plasma exudation. Am J Respir Crit Care Med 1994; 150: 227-232.
44. Minnicozzi M, Duran WN, Gleich GJ, Egan RW. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol 1994; 153: 2664.
45. Chung KF, Barnes PJ, eds, Pharmacology of the Respiratory Tract. New York, Dekker, 1993.
46. Hurley JV. Types of pulmonary microvascular injury. Ann NY Acad Sci 1992; 384: 269-286.
47. Liu MC, Hubbard WC, Proud D, et al. Immediate and late inflammatory responses to ragweed antigen challenge in the peripheral airways in asthmatic airways. Am Rev Respir Dis 1991; 144: 51-58.
48. Erjefält I, Greiff L, Alkner U, Persson CGA. Allergen-induced biphasic plasma exudation responses in guineapig large airways. Am Rev Respir Dis 1993; 148: 695-701.
49. O'Donnell SR, Erjefält I, Persson CGA. Early and late tracheobronchial plasma exudation factor administered to the airway mucosal surface in guinea-pigs: effects of WEB 2086 and enprofylline. J Pharmacol Exp Ther 1990; 254: 65-70.
50. Persson CGA. Airway microcirculation, epithelium, and glucocorticoids. In: Schleimer RP, Busse WW, O'Byrne PM, eds. Inhaled Glucocorticoids in Asthma, Mechanisms and Clinical Actions. New York, Dekker, 1997; pp. 167-201.
51. 2-macroglobulin. Biochem J 1987; 245: 781-787.
52. Persson CGA, Alkner U, Andersson M, Greiff L, Linden M, Svensson C. Histamine challenge-induced "lamina propria lavage" and mucosal output of IL-6 in human airways. Eur Respir J 1995; 8: Suppl. 19, 125s.
53. Woolley KL, Ådelroth E, Woolley MJ, Jordana M, O'Byrne PM. Effects of allergen challenge on eosinophils, eosinophil cationic protein and granulocyte-macrophage colony-stimulating factor in mild asthmatics. Am J Respir Crit Care Med 1995; 151: 1915-1924.
54. 2-macroglobulin and ECP in children with seasonal allergic rhinitis (Abstract). Am J Respir Crit Care Med 1997; 155: A979.
55. Greiff L, Andersson M, Svensson C, Linden M, Wollmer P, Persson CGA. Dual induction of plasma exudation and sputum unravels bronchial eosinophil activity in seasonal allergic rhinitis. Thorax 1998; in press.
56. Schoonbrood DFM, Lutter R, Habets FJM, Roos CM, Jansen HM, Out TA. Analysis of plasma protein leakage and local secretion in sputum from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1519-1527.
57. Persson CGA, Erjefält JS. Airway epithelial restitution following shedding and denudation. In: Crystal RG, West JB, Weibel ER, Barnes PJ, eds. The Lung: Scientific Foundations, 2nd ed. New York, Raven, 1997; pp. 2611-2627.
58. Erjefalt JS, Erjefält I, Sundler F, Persson CGA. In vivo restitution of airway epithelium. Cell Tissue Res 1995; 281: 305-316.
59. Erjefält JS, Korsgren M, Nilsson MC, Sundler F, Persson CGA. Association between inflammation and epithelial damage-restitution processes in allergic airways in vivo. Clin Exp Allergy 1997; 27: 1344-1355.
60. Erjefält JS, Korsgren M, Nilsson MC, Sundler F, Persson CGA. Prompt epithelial damage- and restitution-processes in allergen challenged guinea-pig trachea. Clin Exp Allergy 1997; 27: 1458-1470.
61. Persson CGA, Erjefält JS, Erjefält I, Korsgren M, Nilsson M, Sundler F. Epithelial shedding-restitution as a causative process in airway inflammation. J Clin Exp Allergy 1996; 26: 746-755.
62. Erjefält JS, Persson CGA. Airway epithelial repair: breathtakingly quick and multipotentially pathogenic. Thorax 1997; 52: 1010-1012.
63. Wilhelm DL. Regeneration of tracheal epithelium. J Pathol Bacteriol 1953; 95: 543-550.
64. Persson CGA, Erjefält JS. Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharmacol Sci 1997; 18: 117-123.
65. Dunnill MS. The pathology of asthma with special reference to the change in the bronchial mucosa. J Clin Pathol 1960; 13: 27-33
66. Naylor B. The shedding of the mucosa of the bronchial tree in asthma. Thorax 1962; 17: 69-72.
67. Persson CGA. Centennial notions of asthma as an eosinophilic, desquamative, exudative, and steroid-sensitive disease. Lancet 1977; 350: 1021-1024.
68. Erjefält JS, Greiff L, Andersson M, Persson G, Svensson C, Persson CGA. Eosinophil lysis and clusters of free eosinophil granules (Cfegs) in rhinitis and asthma. (Abstract). Am J Respir Crit Care Med 1997; 155: A977.
69. Greiff L, Andersson M, Svensson C, Lundin S, Wollmer P, Persson CGA. Reduced airway absorption in seasonal allergic rhinitis. Am J Respir Crit Care Med 1997; 156: 783-786.
70. Persson CGA. Role of plasma exudation in asthmatic airways. Lancet 1986; 2: 1126-1129.
71. Jeffery PK. Pathology of asthma. Br Med Bull 1992; 48: 23-29.
72. Åkerlund A, Greiff L, Andersson M, Bende M, Alkner U, Persson CGA. Mucosal exudation of fibrinogen in corona virus-induced common cold. Acta Otolaryngol (Stockh) 1993; 113: 642-648.
73. Svensson C, Andersson M, Greiff L, Alkner U, Persson CGA. Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995; 25: 942-950.
74. Greiff L, Andersson M, Åkerlund A, et al. Microvascular exudative hyperresponsiveness in human corona virus-induced common cold. Thorax 1994; 49: 121-127.
75. Erjefâlt I, Persson CGA. Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways. Am Rev Respir Dis 1991; 144: 788-791.
76. Keal EE. Biochemistry and rheology of sputum in asthma. Postgrad Med J 1971; 47: 171-177.
77. Persson CGA. Airway mucosal exudation of plasma. In: Takishima T, Shimura S, eds. Airway Secretion. Physiological Bases for the Control of mucous Hypersecretion. New York, Dekker, 1994; pp. 451-468.
78. Van de Graaf EA, Out TA, Roos CM, Jansen HM. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991; 143: 362-368.
79. Svensson C, Klementsson H, Andersson M, Pipkorn U, Alkner U, Persson CGA. Glucocorticoid-induced attenuation of mucosal exudation of bradykinins and fibrinogen in seasonal allergic rhinitis. Allergy 1994; 49: 177-183.
80. Farr BM, Gwaltney JM Jr, Hendley JO. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162: 1173-1177.
81. Greiff L, Andersson M, Svensson C, Åkerlund A, Alkner U, Persson CGA. Effects of two weeks' topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways. Eur Respir J 1997; 10: 841-845.
82. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Effects of topical budesonide on epithelial restitution in vivo in guinea-pig trachea. Thorax 1995; 50: 785-792.
83. Schleimer RP, Busse WW, O'Byrne PM, eds. Inhaled Glucocorticoids in Asthma. Mechanisms and Clinical Actions. New York, Dekker, 1997.
84. Persson CGA. Discoveries in complex biosystems. Nature Biotech 1997; 15:927.
85. Persson CGA, Erjefält JS, Korsgren M, Sundler F. The mouse trap. Trends Pharmacol Sci 1997; 18: 465-467.